After snatching up Shire's cancer unit, French pharma giant Servier to expand US presence with Kendall Square innovation office
Servier, the French pharma giant that just acquired Shire’s oncology unit for $2.4 billion, is putting a US innovation outpost in Kendall Square. The new unit will be called Servier BioInnovation, and it’s just recruited two executives to head it up — likely hunters for partnerships and tech that will advance Servier’s pipeline.
This marks the second French pharma giant to announce a Kendall Square outpost in the past 24 hours. Just yesterday, Ipsen announced it was moving its US headquarters from New Jersey to Boston.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.